ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 0492

Axial Spondyloarthritis in Patients with Late-Onset Chronic Low Back Pain (Older Than 45 Years). Axial Spa or Psoriatic Disease with Axial Involvement?

rodrigo garcía salinas1, Gisel Reyes2, Rosario Jaldín Céspedes2, Felica Almada2 and Sebastián Juan Magri3, 1Arthritis and Spondyloarthritis Unit, Hospital Italiano de La Plata, National University of La Plata, La Plata, Argentina, 2Hospital Italiano de La Plata, La Plata, Argentina, 3Hospital Italiano La Plata, Melchor Romero, Argentina

Meeting: ACR Convergence 2023

Keywords: Back pain, Psoriatic arthritis, spondyloarthritis

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Date: Sunday, November 12, 2023

Title: (0483–0509) Spondyloarthritis Including Psoriatic Arthritis – Diagnosis, Manifestations, & Outcomes Poster I: PsA

Session Type: Poster Session A

Session Time: 9:00AM-11:00AM

Background/Purpose:
It is known that patients diagnosed with axSpA do not subsequently meet the classification criteria. The Objectives are: To estimate the diagnostic prevalence of axSpA in patients who started low back pain over 45 years of age and to analyze the clinical, laboratory and imaging differences with patients who started it before that age.

Methods:

Methods: Observational and cross-sectional study, which included patients older than 18 years with a diagnosis of axial spondyloarthritis performed between 2017 and 2021. At baseline, all patients underwent: blood tests, HLA B27, X-rays and MRI of the sacroiliac joint, enthesis ultrasound, sociodemographic data, level of education and habits were also recorded. Axial spondyloarthritis symptoms, age of onset, delay to diagnosis, characteristics of low back pain, characteristics of axial spondyloarthritis, NSAIDs intake and response, VAS pain and night pain, morning stiffness time. In addition, BASDAI, BASFI, MASES and HAQ scores were used. The symptom evaluator was unaware of the results of the complementary studies that were collected by another observer. The MRIs recorded the presence of any lesion and classified it into acute (edema) and chronic (fatty changes, erosions, sclerosis, and bone bridges) lesions.

Results:

Results: One hundred sixteen patients with a diagnosis of axial spondyloarthritis were included, whose characteristics are summarized in Table 1. The prevalence of patients who started low back pain after the age of 45 was 31.28% (95% CI 20-36 ). The relevant differences were: female sex (51% vs 29% p 0.03), smoking (38% vs 57% p 0.07), psoriasis (42% vs 17% p 0.007), good response to NSAIDs (52% vs 73% p 0.03), HLA-B27 (+) (32% vs %54 p 0.04), more than 4 characteristics of axial spondyloarthritis (35% vs 54% p 0.08), BASFI (5.1 vs 4.5 p 0.05), delay to diagnosis in months (40 vs 93 p 0.002). No differences were found in terms of disease activity and imaging (MRI or X-rays). In the logistic regression analysis, the variables that were independently associated were: male sex (OR 0.2 IC95% 0.06- 0.8), psoriasis (OR 4.8 IC95% 1.1-29), and shorter delay to diagnosis (OR 0.9 IC95% 0.96 -0.99).

Conclusion: The prevalence of diagnosis of axial spondyloarthritis in patients who started low back pain after the age of 45 was 28%. The characteristics of these patients were: female sex, higher frequency of psoriasis, and shorter delay to diagnosis. This study shows that the older age at the onset of low back pain and the association with psoriasis could show a group of patients with axial involvement in the context of psoriatic disease.

Supporting image 1

Tabla 1: Patientes´Features.


Disclosures: r. garcía salinas: AbbVie, 1, 2, 5, 6, AstraZeneca, 5, Biogen, 5, Bristol Myers Squibb, 1, 2, 5, 6, Genentech, 5, GlaxoSmithKlein, 5, Janssen, 1, 2, 5, 6, Lilly, 1, 2, 6, Merck Serono, 5, Novartis, 1, 2, 6, Roche, 1, 2, 6, Sandoz, 1, 2, 6; G. Reyes: None; R. Jaldín Céspedes: None; F. Almada: None; S. Magri: None.

To cite this abstract in AMA style:

garcía salinas r, Reyes G, Jaldín Céspedes R, Almada F, Magri S. Axial Spondyloarthritis in Patients with Late-Onset Chronic Low Back Pain (Older Than 45 Years). Axial Spa or Psoriatic Disease with Axial Involvement? [abstract]. Arthritis Rheumatol. 2023; 75 (suppl 9). https://acrabstracts.org/abstract/axial-spondyloarthritis-in-patients-with-late-onset-chronic-low-back-pain-older-than-45-years-axial-spa-or-psoriatic-disease-with-axial-involvement/. Accessed .
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to ACR Convergence 2023

ACR Meeting Abstracts - https://acrabstracts.org/abstract/axial-spondyloarthritis-in-patients-with-late-onset-chronic-low-back-pain-older-than-45-years-axial-spa-or-psoriatic-disease-with-axial-involvement/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology